jian LI. Anti-infective therapy and nursing for a patient with septic shock and acute kidney injury caused by intestinal infection. [DB/OL].Clinical Archives of Integrative Medicine (2023)
DOI:
jian LI. Anti-infective therapy and nursing for a patient with septic shock and acute kidney injury caused by intestinal infection. [DB/OL].Clinical Archives of Integrative Medicine (2023) DOI: 10.12209/CAIM202210300024.
Anti-infective therapy and nursing for a patient with septic shock and acute kidney injury caused by intestinal infection
To report the anti-infective therapy and nursing management for a patient with septic shock and acute kidney injury caused by intestinal infection by Staphylococcus aureus. Changes in the infection markers, blood trough concentration of vancomycin and renal function were dynamically monitored during the treatment. Infection control measures were adopted as the focus of nursing, and whole-course monitoring was carried out. Finally, the condition of patient was improved and the patient was discharged.
QI W Q, ZHANG B, ZHEN Z J, et al. Surviving Sepsis Campaign: The 2021 Surviving Sepsis Campaign Guidelines[J]. Chin J Emerg Med\, 2021, 30(11): 1300-1304. (in Chinese)
ANGUS D C, LINDE-ZWIRBLE W T, LIDICKER J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs ofcare[J]. Crit Care Med, 2001, 29(7): 1303-1310.
DELLINGER R P. Cardiovascular management of septicshock[J]. Crit Care Med, 2003, 31(3): 946-955.
MARTIN G S, MANNION D M, EATON S, et al. The epidemiologyof sepsis in the United States from 1979 through2000[J]. N Engl J Med, 2003, 348(16): 1546-1554.
LINDE-ZWIRBLE W T, ANGUS D C. Severe sepsis epidemiology: sampling, selection, and society[J]. CritCare, 2004, 8(4): 222-226.
CHINESE MEDICAL ASSOCIATION. Chinese Medical Association summit forum of Infection and antimicrobial therapy strategies: Expert consensus on treatment strategy of Methicillin-resistant Staphylococcus aureus infection[J]. Chin J Infect Chemother, 2011, 6: 401-416. (in Chinese)
BOUCHEI H W, COREY G R. Epidemiology of methicillin-resisitant staphylococcus aureus[J]. Clin Infect Dis, 2008, 46: s344-349.
HE N, SU S, ZHAI S D, et al. Evidence-based guideline for therapeutic drug monitoring of Vancomycin:2020 update[J]. Clin Med J, 2021, 19(1): 12-16. (in Chinese)
HUANG X, DENG Z D, NI Y X, et al. Chinese experts' consensus on prevention and control of multidrug resistance organism healthcare-associated infection[J]. Chin J Infect Contr, 2015, 14(1): 1-9. (in Chinese)